Disease/Infection News

RSS

FDA approves Allergan's sNDA to update label for TEFLARO (ceftaroline fosamil)

Allergan plc today announced the U.S. Food and Drug Administration has approved the company's supplemental new drug application (sNDA) to update the label for TEFLARO (ceftaroline fosamil) for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

2 Sep 2015

World Hepatitis Summit highlights need to develop national programmes that can eliminate viral hepatitis

Participants at the first-ever World Hepatitis Summit will urge countries to develop national programmes that can ultimately eliminate viral hepatitis as a problem of public health concern.

2 Sep 2015

UC San Diego-led research team awarded $1.89 million to carry out research on leptospirosis

An international research team, headed by Joseph Vinetz, MD, professor of medicine at University of California, San Diego School of Medicine and director of the UC San Diego Center for Tropical Medicine and Travelers Health, has been awarded a 5-year, $1.89 million cooperative agreement to carry out translational research studies of leptospirosis, an infectious and sometimes fatal bacterial disease endemic in much of the world.

2 Sep 2015

Volatile anesthetics may combat viral and bacterial infections in the lung

In use for more than a century, inhaled anesthetics like nitrous oxide and halothane have made modern surgery possible. Now, in experiments in mice, researchers at Johns Hopkins and elsewhere have added to evidence that certain so-called "volatile" anesthetics -- commonly used during surgeries -- may also possess powerful effects on the immune system that can combat viral and bacterial infections in the lung, including influenza and pneumonia.

2 Sep 2015

Health leaders to deliver presentations at Health Connect South 2015

Health Connect South, a non-profit organization serving the health community as a sustainable platform for regional health collaborations, will convene top innovators, decision makers and leaders from throughout the Southeast to speak at its second annual health leadership event on Wednesday, Sept. 16, 2015 at the Georgia Aquarium.

2 Sep 2015

Bacterial litmus test provides low-cost method to measure blood micronutrients

A bacterium engineered to produce different pigments in response to varying levels of a micronutrient in blood samples could give health officials an inexpensive way to detect nutritional deficiencies in resource-limited areas of the world.

2 Sep 2015

IV drug abusers who undergo infective endocarditis surgery face higher risk of reoperation or death

Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.

1 Sep 2015

ICAAP12 hosts intensive two-day marathon meeting to raise awareness on HIV issues

The International Congress on AIDS in Asia Pacific (ICAAP) 2015 is pleased to announce that it recently concluded an intensive two-day marathon meeting to determine the high-level content of ICAAP12, the 12th International Congress on AIDS in Asia Pacific.

1 Sep 2015

Sleep loss increases chance of catching a cold

A new study led by a UC San Francisco sleep researcher supports what parents have been saying for centuries: to avoid getting sick, be sure to get enough sleep.

1 Sep 2015

New $6.25 million NIH grant to help investigators launch research center to slow and stop HIV

A new five-year, $6.25 million grant from the National Institutes of Health will help investigators from Northwestern University, the University of Chicago and others across the city of Chicago work together to slow and stop HIV.

1 Sep 2015

Multiple HIV-1 variants at the beginning of infection impact viral load setpoints

HIV-1 infection with multiple founder variants points to poorer clinical outcomes than infection with a single variant, according to a paper published today in the journal Nature Medicine.

1 Sep 2015

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

31 Aug 2015

ESC publishes new guidelines on pericardial diseases

New ESC Guidelines on pericardial diseases are published today. Until now there was insufficient evidence for strong recommendations in this group of conditions which can severely restrict quality of life.

29 Aug 2015

New ESC Guidelines on infective endocarditis support role of imaging in diagnosis

ESC Guidelines published today on infective endocarditis boost the role of imaging in diagnosis of this deadly disease.

29 Aug 2015

Novel chemical virus can cross double lipid layer surrounding cells to release drugs

Viruses are able to redirect the functioning of cells in order to infect them. Inspired by their mode of action, scientists from the CNRS and Université de Strasbourg have designed a "chemical virus" that can cross the double lipid layer that surrounds cells, and then disintegrate in the intracellular medium in order to release active compounds.

29 Aug 2015

Oysters play important role in persistence and transmission of norovirus

Oysters not only transmit human norovirus; they also serve as a major reservoir for these pathogens, according to research published August 28 in Applied and Environmental Microbiology, a journal of the American Society for Microbiology. "More than 80 percent of human norovirus genotypes were detected in oyster samples or oyster-related outbreaks," said corresponding author Yongjie Wang, PhD.

29 Aug 2015

Passport Health participates in clinical study to test effects of oral typhoid vaccination

Passport Health, in partnership with vaccine manufacturer PaxVax, Inc. is participating in a clinical study to test the effects of the oral typhoid vaccination, Vivotif (Typhoid Vaccine Live Oral Ty21a). The study will look at the side effects that could occur when taking Vivotif across the range of approved potencies.

28 Aug 2015

Many primary care physicians overestimate their ability to assess Ebola risks in patients

While most primary care physicians responding to a survey taken in late 2014 and early 2015 expressed confidence in their ability to identify potential cases of Ebola and communicate Ebola risks to their patients, only 50 to 70 percent of them gave answers that fit with CDC guidelines when asked how they would care for hypothetical patients who might have been exposed to Ebola.

28 Aug 2015

Findings reveal a new way to prevent meningitis

The fungus Cryptococcus causes meningitis, a brain disease that kills about 1 million people each year — mainly those with impaired immune systems due to AIDS, cancer treatment or an organ transplant.

28 Aug 2015

Cell-to-cell transmission of HIV leads to development of AIDS

Researchers from the Gladstone Institutes have revealed that HIV does not cause AIDS by the virus's direct effect on the host's immune cells, but rather through the cells' lethal influence on one another.

28 Aug 2015

Disease/Infection News

FDA approves Allergan's sNDA to update label for TEFLARO (ceftaroline fosamil)

World Hepatitis Summit highlights need to develop national programmes that can eliminate viral hepatitis

UC San Diego-led research team awarded $1.89 million to carry out research on leptospirosis

Volatile anesthetics may combat viral and bacterial infections in the lung

Health leaders to deliver presentations at Health Connect South 2015

Bacterial litmus test provides low-cost method to measure blood micronutrients

IV drug abusers who undergo infective endocarditis surgery face higher risk of reoperation or death

ICAAP12 hosts intensive two-day marathon meeting to raise awareness on HIV issues

Sleep loss increases chance of catching a cold

New $6.25 million NIH grant to help investigators launch research center to slow and stop HIV

Multiple HIV-1 variants at the beginning of infection impact viral load setpoints

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

ESC publishes new guidelines on pericardial diseases

New ESC Guidelines on infective endocarditis support role of imaging in diagnosis

Novel chemical virus can cross double lipid layer surrounding cells to release drugs

Oysters play important role in persistence and transmission of norovirus

Passport Health participates in clinical study to test effects of oral typhoid vaccination

Many primary care physicians overestimate their ability to assess Ebola risks in patients

Findings reveal a new way to prevent meningitis

Cell-to-cell transmission of HIV leads to development of AIDS

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News